Diagnosing ADHD in adults with substance use disorder: DSM-IV criteria and differential diagnosis
- PMID: 17685729
- DOI: 10.4088/jcp.0707e18
Diagnosing ADHD in adults with substance use disorder: DSM-IV criteria and differential diagnosis
Abstract
Individuals with ADHD have a high rate of comorbid psychiatric disorders, especially substance use disorders. Similarly, ADHD is overrepresented in the SUD population. This high rate of comorbidity can make ADHD difficult to diagnose and treat. Comorbid SUD in individuals with ADHD can have a negative impact on course of illness and quality of life. The stringent DSM-IV criteria for ADHD may make diagnosing ADHD in adults difficult, which may lead to an underdiagnosis of ADHD in the adult population. This may be especially true for patients with SUD, because cognitive deficits associated with substance abuse can hinder their ability to recall ADHD symptoms for appropriate diagnostic purposes. On the other hand, SUD symptoms may mimic ADHD symptoms, which can lead to an overdiagnosis of ADHD in the SUD population. If proper attention is paid to age-appropriate symptoms of ADHD, and careful longitudinal data are obtained from patients presenting with ADHD or SUD, proper treatment can be given to patients with these comorbid disorders.
Similar articles
-
Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders.J Clin Psychiatry. 2007;68 Suppl 11:9-14. J Clin Psychiatry. 2007. PMID: 18307376 Review.
-
Attention Deficit Hyperactivity Disorder in Prisoners: Increased Substance Use Disorder Severity and Psychiatric Comorbidity.Eur Addict Res. 2020;26(4-5):179-190. doi: 10.1159/000508829. Epub 2020 Jul 2. Eur Addict Res. 2020. PMID: 32615575
-
Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity.Am J Addict. 2005 Jul-Sep;14(4):319-27. doi: 10.1080/10550490591003639. Am J Addict. 2005. PMID: 16188712
-
Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.Eur Addict Res. 2020;26(4-5):201-210. doi: 10.1159/000508546. Epub 2020 Jun 22. Eur Addict Res. 2020. PMID: 32570249
-
The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders.Curr Opin Psychiatry. 2012 May;25(3):219-25. doi: 10.1097/YCO.0b013e3283523d7c. Curr Opin Psychiatry. 2012. PMID: 22449768 Review.
Cited by
-
Screening for substance use disorders in neurodevelopmental disorders: a clinical routine?Eur Child Adolesc Psychiatry. 2014 May;23(5):365-8. doi: 10.1007/s00787-013-0459-x. Epub 2013 Aug 15. Eur Child Adolesc Psychiatry. 2014. PMID: 23949101
-
Methylphenidate for Attention-Deficit and Hyperactivity Disorder in Adult Patients With Substance Use Disorders: Good Clinical Practice.Front Psychiatry. 2021 Jan 26;11:540837. doi: 10.3389/fpsyt.2020.540837. eCollection 2020. Front Psychiatry. 2021. PMID: 33574770 Free PMC article. Review.
-
Association of Opioid and Stimulant Use Disorder Diagnoses With Fatal and Nonfatal Overdose Among People With a History of Incarceration.JAMA Netw Open. 2022 Nov 1;5(11):e2243653. doi: 10.1001/jamanetworkopen.2022.43653. JAMA Netw Open. 2022. PMID: 36416821 Free PMC article.
-
[ADHD screening in alcohol dependent subjects : Psychometric characteristics of ADHD self-report scale and Wender Utah Rating Scale short form].Nervenarzt. 2019 Nov;90(11):1156-1161. doi: 10.1007/s00115-019-0706-6. Nervenarzt. 2019. PMID: 30976828 German.
-
Treatment of Adolescents with Concurrent Substance Use Disorder and Attention-Deficit/Hyperactivity Disorder: A Systematic Review.J Clin Med. 2021 Aug 30;10(17):3908. doi: 10.3390/jcm10173908. J Clin Med. 2021. PMID: 34501355 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical